What is the 13F Pro Quality Score for RDNT?

13F Pro ranks RadNet, Inc. (RDNT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View RDNT's current score at https://13fpro.ai/company/RDNT (free sign-up required for the full ranking).

Which hedge funds own the most RDNT stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of RDNT include BlackRock,, RTW INVESTMENTS,, PRICE T ROWE ASSOCIATES /MD/. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/RDNT as soon as new 13F filings post.

Where does 13F Pro source RDNT data?

All RadNet, Inc. fundamentals and ownership data come directly from SEC EDGAR. RadNet, Inc. files with the SEC under CIK 790526. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is RDNT in?

RadNet, Inc. (RDNT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives RDNT's revenue?

Per RadNet, Inc.'s latest 10-Q filed with the SEC on 2026-08-10, the biggest revenue drivers are: Imaging Centers ($601.8M, +23.5% YoY); Digital Health ($32.4M, +56.5% YoY); Service fee revenue ($592.6M, +26.6% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/RDNT.

What are RDNT's largest expenses?

RadNet, Inc.'s latest 10-Q reports these as the largest expense items: Depreciation and amortization ($45.5M, +26.4% YoY); Interest expense ($18.2M, +5.6% YoY). Sourced directly from SEC EDGAR filing text for Q2 2026 (quarter ended June 30, 2026).

How often is RDNT research updated on 13F Pro?

RDNT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

RadNet, Inc.(RDNT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 790526 RDNT stock profile & AI dashboard →

13F Pro Quality Score

58.6/100

Rank #997 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

72.8/100

Profitability

30.9/100

Balance Sheet

31.4/100

Earnings Quality

97.4/100

Free Cash Flow

63.0/100

Institutional Flow

73.2/100

Revenue Scale

65.2/100

Dilution Risk

34.9/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why RDNT Scores 59/100

exact factor attribution · 2026-09-11

RDNT's composite is driven by earnings quality and revenue growth, held back by profitability and capital efficiency. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+4.7 pts

97th pct

Revenue growth

+4.6 pts

73th pct

Scale

+2.3 pts

65th pct

Free cash flow

+1.9 pts

63th pct

Institutional flow

+1.2 pts

73th pct

Earnings growth

-0.6 pts

39th pct

Shareholder dilution

-0.8 pts

35th pct

Capital efficiency

-1.9 pts

31th pct

Profitability

-2.9 pts

31th pct

Latest change (2026-08-10): 51 → 54 · ↑ Profit margin 27→44; ↑ Capital efficiency 31→39; despite ↓ Revenue growth 71→59

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

RDNT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for RadNet, Inc. (RDNT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RDNT at 58.6/100 on a 32-signal composite quality model, placing it at rank #997 of 2,961 stocks — the top half of the AI-ranked universe. RDNT scores in the top quartile across earnings quality (97.4). Areas of concern include profitability (30.9) and balance sheet strength (31.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), RadNet, Inc. reports quarterly revenue of $622.7M, net income of $7.5M, an operating margin of 6.3%. Top institutional holders of RDNT by reported 13-F value include BlackRock, RTW INVESTMENTS, PRICE T ROWE ASSOCIATES, based on the most recent SEC filings. RDNT trades on the Nasdaq exchange and files with the SEC under CIK 790526. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RDNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RadNet, Inc. directly from SEC EDGAR. RadNet, Inc.'s 13F Pro composite quality score has ranged between 44 and 60 since 2021, currently 58.6 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about RadNet, Inc.

Quirks, history, and lore behind RDNT — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · mid-cap · listed on Nasdaq · headquartered in Los Angeles, California.
2
The Numbers
Operates over 400 outpatient imaging centers across the U.S., making it one of the largest networks of its kind in the country.
3
The History
Founded in 1981, it spent decades quietly buying up independent imaging clinics, turning a fragmented mom-and-pop industry into a scaled national platform.
4
The Secret
It's betting big on AI-powered diagnostics to read scans faster and catch what human eyes miss — quietly becoming a tech-forward healthcare company in a lab coat.
5
The Lore
Its home turf of Southern California remains its largest market, and it has expanded into New York, New Jersey, and Maryland — basically wherever bodies need scanning.
6
The Giveaway
If you've ever had an MRI, CT scan, or X-ray at a standalone imaging center in a U.S. strip mall, there's a decent chance the sign outside said RadNet.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving RDNT's Business? Latest 10-Q Breakdown

AI-extracted from RadNet, Inc.'s 10-Q filed 2026-08-10 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

RadNet Q2 revenue reached $622.7M (+25.0% YoY), driven by 11.1% same-center imaging growth and strong Digital Health expansion to $32.4M (+56.5% YoY), though Digital Health segment losses widened.

Biggest Revenue Drivers

Imaging Centers$601.8M+23.5% YoY

Same-center revenue +11.1% driven by higher procedural volumes, increased reimbursement from commercial and capitated payors, and favorable shift to advanced imaging (PET/CT for prostate cancer and Alzheimer's studies).

Digital Health$32.4M+56.5% YoY

Clinical AI revenue increased 135.9%; Enterprise Informatics revenue +17.3%; customer base expanded to 2,983 from 463 YoY; procedure volumes supported increased to 17.3M from 5.3M.

Biggest Revenue Drivers

Total revenue: $622.7M+25.0% YoY

Imaging Centers$601.8M+23.5% YoY

Within Imaging Centers

Service fee revenue$592.6M+26.6% YoY

Commercial insurance $339.4M (+21.8% YoY), Medicare $150.8M (+29.7% YoY), other payors contributed remaining balance.

Digital Health$32.4M+56.5% YoY

Clinical AI revenue increased 135.9%; Enterprise Informatics revenue +17.3%; customer base expanded to 2,983 from 463 YoY; procedure volumes supported increased to 17.3M from 5.3M.

Capitation arrangements revenue$30.1M-0.1% YoY

Per-enrollee monthly arrangements with health plans remained stable.

Largest Expense Items

Depreciation and amortization$45.5M+26.4% YoY

Higher depreciable asset base from acquisitions and capital investments during period.

Interest expense$18.2M+5.6% YoY

Adjusted interest expense (excluding derivatives) decreased 0.6% to $17.4M; benefits from 0.25% rate reduction offset by higher average debt balances from $250M incremental term loan.

Margins: Imaging Centers segment profit margin improved to 15.4% ($92.8M) from 15.0% ($73.1M) YoY despite 11.9% same-center operating leverage, driven by labor efficiency and workflow optimization including early DeepHealth deployment. Digital Health segment operating loss widened to $14.6M from $7.1M, reflecting integration costs of Gleamer, iCAD, See-Mode and CIMAR acquisitions and continued investments in AI platform scaling.

Watch Items from the Filing

Digital Health segment operating losses accelerated to $14.6M in Q2 2026 vs. $7.1M in Q2 2025 and $32.3M for six months ended June 30, 2026 vs. $13.2M YoY; segment expected to remain unprofitable near-term despite $105.5M ARR (+97% YoY).
Goodwill increased $218.6M to $1,122.5M (6M period) primarily from Gleamer ($171.1M goodwill recorded); company noted no impairment indicators as of June 30, 2026 but digital acquisitions carry execution and integration risk.
Term loan debt increased to $1,323.7M from $1,084.9M at year-end 2025 due to $250M incremental borrowing in June 2026; quarterly principal payments rose to $3.1M; maturity April 18, 2031.
On August 1, 2026 (subsequent event), RadNet restructured Maryland imaging joint ventures to form Maryland Imaging Partners, LLC retaining 80% ownership and contributing six wholly-owned Maryland centers; now operates 19 Maryland imaging centers.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$622.7M

Net Income

Q2 2026

$7.5M

Operating Margin

Q2 2026

6.3%

ROIC

Q2 2026

6.4%

D/E Ratio

Q2 2026

1.25

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+11.5% YoY

$2.04BFY 2025

FY22 $1.43BFY23 $1.62BFY24 $1.83BFY25 $2.04B

Net Income

-767.8% YoY

$-18.7MFY 2025

FY22 $10.7MFY23 $3.0MFY24 $2.8MFY25 $-18.7M

Operating Income

-40.7% YoY

$62.0MFY 2025

FY22 $46.4MFY23 $98.7MFY24 $104.6MFY25 $62.0M

EPS (Diluted)

-725.0% YoY

$-0.25FY 2025

FY22 $0.17FY23 $0.05FY24 $0.04FY25 $-0.25

Total Assets

+14.4% YoY

$3.76BFY 2025

FY22 $2.43BFY23 $2.69BFY24 $3.29BFY25 $3.76B

Total Debt

+7.1% YoY

$1.12BFY 2025

FY22 $864.1MFY23 $848.0MFY24 $1.04BFY25 $1.12B

Op. Cash Flow

+28.2% YoY

$298.8MFY 2025

FY22 $146.4MFY23 $220.9MFY24 $233.0MFY25 $298.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$2.04B +11.5%	$1.83B +13.2%	$1.62B +13.0%	$1.43B +8.7%	$1.32B +22.7%	$1.07B
Net Income	$-18.7M -767.8%	$2.8M -8.2%	$3.0M -71.4%	$10.7M -56.9%	$24.7M +266.6%	$-14.8M
Operating Income	$62.0M -40.7%	$104.6M +6.0%	$98.7M +112.9%	$46.4M -43.8%	$82.6M +131.3%	$35.7M
EPS (Diluted)	$-0.25 -725.0%	$0.04 -20.0%	$0.05 -70.6%	$0.17 -63.0%	$0.46 +258.6%	$-0.29
Total Assets	$3.76B +14.4%	$3.29B +22.2%	$2.69B +10.5%	$2.43B +18.2%	$2.06B +15.2%	$1.79B
Total Debt	$1.12B +7.1%	$1.04B +22.8%	$848.0M -1.9%	$864.1M +12.8%	$765.8M +9.1%	$702.2M
Operating Cash Flow	$298.8M +28.2%	$233.0M +5.5%	$220.9M +50.8%	$146.4M -2.1%	$149.5M -36.0%	$233.8M

Get alerted when RDNT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for RadNet, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of RDNT

BlackRock, Inc.
$675.8M10,957,808 sh
RTW INVESTMENTS, LP
$298.9M4,846,958 sh
PRICE T ROWE ASSOCIATES INC /MD/
$277.6M4,501,195 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$250.8M4,066,931 sh
VANGUARD CAPITAL MANAGEMENT LLC
$196.9M3,193,565 sh
BECK MACK & OLIVER LLC
$195.1M3,163,592 sh
STATE STREET CORP
$175.2M2,842,457 sh
GEODE CAPITAL MANAGEMENT, LLC
$114.6M1,858,508 sh
Invesco Ltd.
$101.2M1,641,292 sh
AMERICAN CENTURY COMPANIES INC
$99.8M1,618,424 sh

Fund	Value	Shares
BlackRock, Inc.	$675.8M	10,957,808
RTW INVESTMENTS, LP	$298.9M	4,846,958
PRICE T ROWE ASSOCIATES INC /MD/	$277.6M	4,501,195
VANGUARD PORTFOLIO MANAGEMENT LLC	$250.8M	4,066,931
VANGUARD CAPITAL MANAGEMENT LLC	$196.9M	3,193,565
BECK MACK & OLIVER LLC	$195.1M	3,163,592
STATE STREET CORP	$175.2M	2,842,457
GEODE CAPITAL MANAGEMENT, LLC	$114.6M	1,858,508
Invesco Ltd.	$101.2M	1,641,292
AMERICAN CENTURY COMPANIES INC	$99.8M	1,618,424

Companies Similar to RDNT

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

COO

COOPER COMPANIES, INC.

AI score

Similar quality profile · 11 shared holders

BAMCO INC /NY/ROYCE & ASSOCIATES LP SEB Asset Management AB

NTRA

Natera, Inc.

AI score

Similar quality profile · 10 shared holders

RTW INVESTMENTS, LP Clearbridge Investments, LLC WESTFIELD CAPITAL MANAGEMENT CO LP

AXGN

Axogen, Inc.

AI score

Similar quality profile · 15 shared holders

Hood River Capital Management LLC RTW INVESTMENTS, LP Polar Capital Holdings Plc

IRTC

iRhythm Holdings, Inc.

AI score

Similar quality profile · 18 shared holders

RTW INVESTMENTS, LP LOOMIS SAYLES & CO L P Polar Capital Holdings Plc

LFST

LifeStance Health Group, Inc.

AI score

Similar quality profile · 7 shared holders

JENNISON ASSOCIATES LLC LOOMIS SAYLES & CO L P First Eagle Investment Management, LLC

SUPN

SUPERNUS PHARMACEUTICALS, INC.

AI score

Similar quality profile · 8 shared holders

LOOMIS SAYLES & CO L P ROYCE & ASSOCIATES LP CAMPBELL NEWMAN ASSET MANAGEMENT INC

GKOS

GLAUKOS Corp

AI score

Similar quality profile · 16 shared holders

Clearbridge Investments, LLC WESTFIELD CAPITAL MANAGEMENT CO LP LOOMIS SAYLES & CO L P

WRBY

Warby Parker Inc.

AI score

Similar quality profile · 8 shared holders

JENNISON ASSOCIATES LLC SILVERCREST ASSET MANAGEMENT GROUP LLC First Eagle Investment Management, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put RDNT on your watchlist

Track score changes the day RadNet, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is RDNT a good stock to buy?

13F Pro's AI-powered analysis of RadNet, Inc. (RDNT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RDNT are available on the RDNT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. RDNT is classified as a mid company.

Which hedge funds own RDNT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RDNT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of RadNet, Inc.'s investment landscape.